Skip to content

Bioventus BVS Current Debt

Current Debt at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.18B+96.0%
Medtronic logo
MedtronicMDT
$1.79B-37.8%
Artivion logo
ArtivionAORT
$0-100%
Avanos Medical logo
Avanos MedicalAVNS
$10.9M+16.0%
Enovis logo
EnovisENOV
$35M+74.8%
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's current debt?
Bioventus (BVS) reported current debt of $18.75M in Q1 2026.
How has Bioventus's current debt changed year-over-year?
Bioventus's current debt decreased by 49.8% year-over-year, from $37.34M to $18.75M.
What is the long-term trend for Bioventus's current debt?
Over 5 years (2020 to 2025), Bioventus's current debt has grown at a 0.0% compound annual growth rate (CAGR), from $15M to $15M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.